A Study to Compare the Efficacy and Safety of Lisocabtagene Maraleucel vs Investigator's Choice Options in Adult Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Whose Disease Has Failed Treatment With Both BTKi and BCL2i Therapies
Clinical trial NCT06205290 · WITHDRAWN
Trial details
- NCT number
- NCT06205290
- Sponsor
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-16
- Primary completion
- 2031-10-13
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.